13D filed by SV Biotech Crossover Opportunities Fund LP
SV Biotech Crossover Opportunities Fund LP and 1 other reporting person reported 1,920,667 TRXB shares, 7% of the class, as of 2026-10-08, in a 13D accepted by EDGAR 2026-10-16 19:53:17 UTC.
- Accession
- 0001829126-26-011242
- Filer
- CIK 1903934
- Filed
- 2026-10-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- TRXB · TRex Bio, Inc.
- Shares
- 1,920,667
- Percent of class
- 7%
- Event date
- 2026-10-08
How the shares relate across the reporting persons: every reporting person reports the same shares (a chain of control). The page shows the largest row.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| SV Biotech Crossover Opportunities Fund LP | PN | 1,920,667 | 0 | 1,920,667 | 0 | 1,920,667 | 7% |
| SV BCO I GP LLP | PN | 1,920,667 | 0 | 1,920,667 | 0 | 1,920,667 | 7% |